Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.47 |
| ▸ | FAAH | O00519 | 2/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.44 |
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.42 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3081783 | 1.00 | CA1 (0.53) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL28233476 | 1.00 | CA1 (0.53) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL27967468 | 0.92 | CA1 (0.47) | CA1ACE2ZDHHC7FDPS | |
| SCHEMBL9547826 | 0.84 | CA1 (0.35) | CA1ACE2ZDHHC7FAAH | |
| SCHEMBL27842678 | 0.84 | CA1 (0.35) | CA1ACE2ZDHHC7FAAH | |
| SCHEMBL8052116 | 0.83 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL27321446 | 0.83 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL15754145 | 0.83 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL8994069 | 0.83 | CA1 (0.57) | CA1ACE2ZDHHC7FAAHFFAR1 | |
| SCHEMBL9645822 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928402-B1 | Carnitine derivative, salt thereof, external skin preparation and cosmetic preparation | SHOWA DENKO KK (JP) | 2014-03-12 | — | — | EP | disclosed |
| US-7842726-B2 | Carnitine derivative, salt thereof, external skin preparation and cosmetic material | SHOWA DENKO K.K. (JP) | 2010-11-30 | — | — | US | disclosed |
| US-20100280111-A1 | SKIN EXTERNAL PREPARATIONS AND COSMETICS | SHOWA DENKO K.K. (JP) | 2010-11-04 | — | — | US | disclosed |
| US-20100273877-A1 | EMULSIFIED SKIN EXTERNAL PREPARATIONS AND COSMETICS | SHOWA DENKO K.K. (JP) | 2010-10-28 | — | — | US | disclosed |
| EP-2238970-A1 | EMULSION PREPARATION FOR EXTERNAL APPLICATION TO SKIN AND COSMETIC PREPARATION | Showa Denko K.K. (JP) | 2010-10-13 | — | — | EP | disclosed |
| EP-2238969-A1 | PREPARATION FOR EXTERNAL APPLICATION TO SKIN AND COSMETIC PREPARATION | Showa Denko K.K. (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-20090234153-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO K.K. (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-1928402-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | Showa Denko K.K. (JP) | 2008-06-11 | — | — | EP | disclosed |
| WO-2007043339-A9 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO KK (JP) | 2007-06-07 | — | — | WO | disclosed |
| WO-2007043339-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | SHOWA DENKO K.K. (JP) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100273877-A1 | EMULSIFIED SKIN EXTERNAL PREPARATIONS AND COSMETICS | CUTA, CRAT, SLC25A20 | CA1 3740/4885ACE2 4487/4885ZDHHC7 32/4885 |
| US-20090234153-A1 | CARNITINE DERIVATIVE, SALT THEREOF, EXTERNAL SKIN PREPARATION AND COSMETIC MATERIAL | CRAT, CUTA, SLC25A20 | CA1 2438/4885ACE2 3018/4885ZDHHC7 94/4885 |
| US-20100280111-A1 | SKIN EXTERNAL PREPARATIONS AND COSMETICS | H1-0, H1-2, CUTA | CA1 2091/4885ACE2 4723/4885ZDHHC7 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.